A Big Data Approach Toward the Development of New Quantitative Autism Severity Scores from Existing Instruments
A Big Data Approach Toward the Development of New Quantitative Autism Severity Scores from Existing Instruments
批准号:
10438954
负责人:
Thomas William Frazier
金额:
$38.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-07 至 2025-06-06
关键词:
Adaptive BehaviorsAgeAlgorithmsBig DataClinicalCognitiveCollaborationsComplexComputer softwareDataData AnalysesData ScienceData ScientistData SetDatabasesDevelopmentDiagnosisEquationEtiologyFosteringFutureGoldIndividualInternationalInterventionIntervention StudiesInvestigationKnowledgeLanguageLeadLinkLiteratureMeasuresMechanicsMental HealthMethodsModelingModernizationMonitorNeurobiologyOutcomePatientsPerformanceProblem behaviorPsychometricsQuestionnairesResearchResearch InfrastructureResourcesScientistSeveritiesSpecificityStatistical MethodsStructureStudentsSymptomsTimeTrainingTraining ProgramsValidationautism diagnostic observation scheduleautism spectrum disorderbaseclinical practicecognitive abilitycohortcomorbiditycostcost effectiveexperienceimprovedindexinginnovationinstrumentlarge datasetslongitudinal datasetnext generationprogramspsychiatric symptomrepetitive behaviorresponsesexsocialsocial factorstertiary caretheoriesundergraduate researchundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Autism spectrum disorder (ASD) symptom scores from existing measures are influenced by a range of factors
including age, sex, cognitive ability, language level, co-occurring psychiatric symptoms and behavioral
problems. Inadequate adjustment of assessment scores can lead to reduced specificity and mis-estimation of
autism severity. Adjustment for these factors could enhance research and clinical practice, including more
accurate estimation of true relationships with other variables, including etiologic factors, and better case
identification, particularly for complex cases. In addition, the majority of currently available ASD measures have
reduced ability to track change and response to interventions and are not linked to adaptive functioning, which
is being increasingly recognized as one of the most relevant to long term outcomes in ASD. Considering these
noted limitations, enhancing the performance of current measures could advance clinical practice and future
research. The proposed project will focus on the Social Responsiveness Scale (SRS-2), the most widely used
quantitative symptom questionnaire, and the Autism Diagnostic Observation Schedule–Second Edition (ADOS-
2), the gold-standard clinician observation measure. The investigation will utilize existing multiple high-quality
large data sets and apply modern psychometric approaches in order to create new continuous-range,
regression-adjusted, normative SRS-2 and ADOS-2 scores that can supplement existing scores. These scores
will have better specificity for autism symptom domains, more direct links to adaptive function and, when used
alone or in conjunction with existing scores, may yield greater validity for ASD diagnosis in complex, highly
comorbid cases (Specific Aims 1 and 2). By virtue of having dynamic range and being more specifically related
to core ASD symptom domains, newly created SRS-2 and ADOS-2 scores could have greater utility in
longitudinal applications, including treatment studies and clinical monitoring of intervention response (Specific
Aim 3). Knowledge gained from this innovative secondary data analysis will then be used to develop and pilot
software-implemented scoring algorithms to account for relevant demographic, cognitive and clinical factors
(Specific Aim 4). If successful, this approach will provide a low-cost enhancement to existing, widely-used
measures that can be rapidly disseminated to clinicians and scientists for improving practice and research. The
proposed AREA project will also include three cohorts of undergraduate students to build a cross-departmental
and cross-institutional mental health data science training experience that can be sustained as a future
undergraduate research track and as an international research collaboration focused on autism spectrum
disorder. Students will be involved in all aspects of the project from database building to dissemination and the
project will build key undergraduate research infrastructure as well as augment training for the next generation
of mental health data scientists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: